Highly specific epigenome editing by CRISPR-Cas9 repressors for silencing of distal regulatory elements

Thakore, Pratiksha I, D'Ippolito, Anthony M, Song, Lingyun, Safi, Alexias, Shivakumar, Nishkala K, Kabadi, Ami M, Reddy, Timothy E, Crawford, Gregory E +1 more·2015·Nature Methods
DOI 10.1038/nmeth.3630

Cited by (1,000)

Items 301–400 of 1,000

  1. Temporal and Spatial Epigenome Editing Allows Precise Gene Regulation in Mammalian Cells
    Cem Kuscu, Rashad Mammadov, Ágnes Czikora, Hayrunnisa Unlu, Turan Tufan, Natasha Lopes Fischer, Şevki Arslan, Stefan Bekiranov, Masato T. Kanemaki, Mazhar Adli · 2018 · Journal of Molecular Biology
  2. KLF4 protein stability regulated by interaction with pluripotency transcription factors overrides transcriptional control
    Navroop K. Dhaliwal, Luis E. Abatti, Jennifer A. Mitchell · 2019 · Genes & Development
  3. Transposable Elements Are Co-opted as Oncogenic Regulatory Elements by Lineage-Specific Transcription Factors in Prostate Cancer
    Giacomo Grillo, Tina Keshavarzian, Simon Linder, Christopher Arlidge, Lisanne Mout, Ankita Nand, Mona Teng, Aditi Qamra, Stanley Zhou, Ken J. Kron et al. · 2023 · Cancer Discovery
  4. Epigenetics and individuality: from concepts to causality across timescales
    Amy K. Webster, Patrick C. Phillips · 2025 · Nature Reviews Genetics
  5. Synthetic biology — application-oriented cell engineering
    Mingqi Xie, Viktor Haellman, Martin Fussenegger · 2016 · Current Opinion in Biotechnology
  6. Exploiting CRISPR Cas9 in Three-Dimensional Stem Cell Cultures to Model Disease
    Sneha Gopal, André Lopes Rodrigues, Jonathan S. Dordick · 2020 · Frontiers in Bioengineering and Biotechnology
  7. Single-cell RNA sequencing uncovers the nuclear decoy lincRNA PIRAT as a regulator of systemic monocyte immunity during COVID-19
    Marina Aznaourova, Nils Schmerer, Harshavardhan Janga, Zhenhua Zhang, Kim Pauck, Judith Bushe, Sarah M. Volkers, Daniel Wendisch, Philipp Georg, Evgenia Ntini et al. · 2022 · Proceedings of the National Academy of Sciences
  8. Optimization of Cas9 activity through the addition of cytosine extensions to single-guide RNAs
    Masaki Kawamata, Hiroshi I. Suzuki, Ryota Kimura, Atsushi Suzuki · 2023 · Nature Biomedical Engineering
  9. The potential of CRISPR/Cas9 genome editing for the study and treatment of intervertebral disc pathologies
    Olga Krupkova, Elena Cambria, Lenka Bešše, Andrej Bešše, Robert Bowles, Karin Wuertz‐Kozak · 2018 · JOR Spine
  10. Loop competition and extrusion model predicts CTCF interaction specificity
    Xi Wang, M Beer · 2021 · Nature Communications
  11. Genome engineering of stem cell organoids for disease modeling
    Sun, Yingmin, Ding, Qiurong · 2017 · Protein & Cell
  12. Targeting long non-coding RNAs in cancer therapy using CRISPR-Cas9 technology: A novel paradigm for precision oncology
    Rahul Kumar Mahato, Srinjan Bhattacharya, Naina Khullar, Inderpal Singh Sidhu, P. Hemachandra Reddy, Gurjit Kaur Bhatti, Jasvinder Singh Bhatti · 2023 · Journal of Biotechnology
  13. Advances in targeting cancer epigenetics using CRISPR-dCas9 technology: A comprehensive review and future prospects
    Jeevitha Rajanathadurai, Elumalai Perumal, Jospin Sindya · 2024 · Functional & Integrative Genomics
  14. Randomized CRISPR-Cas Transcriptional Perturbation Screening Reveals Protective Genes against Alpha-Synuclein Toxicity
    Ying-Chou Chen, Fahim Farzadfard, Nava Gharaei, William C. W. Chen, Jicong Cao, Timothy K. Lu · 2017 · Molecular Cell
  15. Prostate cancer research: The next generation; report from the 2019 Coffey‐Holden Prostate Cancer Academy Meeting
    Andrea K. Miyahira, Adam Sharp, Leigh Ellis, Jennifer Clare Jones, Salma Kaochar, H. Benjamin Larman, David Alan Quigley, Huihui Ye, Jonathan W. Simons, Kenneth J. Pienta et al. · 2019 · The Prostate
  16. Targeted brachyury degradation disrupts a highly specific autoregulatory program controlling chordoma cell identity
    Hadley E. Sheppard, Alessandra Dall’Agnese, Woojun Daniel Park, Md Shamim, Julien Dubrulle, Hannah L. Johnson, Fabio Stossi, Patricia C. Cogswell, Josh Sommer, Joan B. Levy et al. · 2021 · Cell Reports Medicine
  17. CRISPRi links COVID-19 GWAS loci to LZTFL1 and RAVER1
    Iris M. Fink-Baldauf, William D. Stuart, John J. Brewington, Minzhe Guo, Yutaka Maeda · 2022 · EBioMedicine
  18. Myoediting: Toward Prevention of Muscular Dystrophy by Therapeutic Genome Editing
    Yu Zhang, Chengzu Long, Rhonda Bassel‐Duby, Eric N. Olson · 2018 · Physiological Reviews
  19. Applications of Lgr5-Positive Cochlear Progenitors (LCPs) to the Study of Hair Cell Differentiation
    Danielle R. Lenz, Niliksha Gunewardene, Dunia Abdul‐Aziz, Quan Wang, Tyler M. Gibson, Albert S.B. Edge · 2019 · Frontiers in Cell and Developmental Biology
  20. Targeted in vivo epigenome editing of H3K27me3
    Hiroto S. Fukushima, Hiroyuki Takeda, Ryohei Nakamura · 2019 · Epigenetics & Chromatin
  21. Combinatorial chromatin dynamics foster accurate cardiopharyngeal fate choices
    Claudia Racioppi, Keira Wiechecki, Lionel Christiaen · 2019 · eLife
  22. CRISPR/Cas9 Technology: Applications and Human Disease Modeling
    Marta Martínez-Lage, Raúl Torres-Ruiz, Sandra Rodríguez · 2017 · Progress in molecular biology and translational science
  23. Synthetic immunomodulation with a CRISPR super-repressor in vivo
    Farzaneh Moghadam, Ryan LeGraw, Jeremy J. Velazquez, Nan Cher Yeo, Chenxi Xu, Jin Hyoung Park, Alejandro Chavez, Mo R. Ebrahimkhani, Samira Kiani · 2020 · Nature Cell Biology
  24. Systematic discovery and functional dissection of enhancers needed for cancer cell fitness and proliferation
    Po-Shen B. Chen, Patrick C. Fiaux, Kai Zhang, Bin Li, Naoki Kubo, Shan Jiang, Rong Hu, Emma Rooholfada, Si-Han Wu, Meng-Chi Wang et al. · 2022 · Cell Reports
  25. Cas9 Functionally Opens Chromatin
    Amira A. Barkal, Sharanya Srinivasan, Tatsunori Hashimoto, David Kenneth Gifford, Richard I. Sherwood · 2016 · PLoS ONE
  26. Combining Induced Pluripotent Stem Cells and Genome Editing Technologies for Clinical Applications
    Chia-Yu Chang, Hsiao-Chien Ting, Hong‐Lin Su, Jing‐Ren Jeng · 2018 · Cell Transplantation
  27. Mathematical Modeling of RNA-Based Architectures for Closed Loop Control of Gene Expression
    Deepak Kumar Agrawal, Xun Tang, Alexandra M. Westbrook, Ryan Marshall, Colin S. Maxwell, Julius B. Lucks, Vincent Noireaux, Chase L. Beisel, Mary J. Dunlop, Elisa Franco · 2018 · ACS Synthetic Biology
  28. The Intricate Interplay between Epigenetic Events, Alternative Splicing and Noncoding RNA Deregulation in Colorectal Cancer
    Raheleh Amirkhah, Hojjat Naderi‐Meshkin, Jaynish S. Shah, Philip D. Dunne, Ulf Schmitz · 2019 · Cells
  29. Dynamic spreading of chromatin-mediated gene silencing and reactivation between neighboring genes in single cells
    Sarah Lensch, Michael H. Herschl, Connor Ludwig, Joydeb Sinha, Michaela M. Hinks, Adi Xiyal Mukund, Taihei Fujimori, Lacramioara Bintu · 2022 · eLife
  30. Identifying oligodendrocyte enhancers governing Plp1 expression
    Dongkyeong Kim, Hongjoo An, Chuandong Fan, Yungki Park · 2021 · Human Molecular Genetics
  31. Development of Polymer–Lipid Hybrid Nanoparticles for Large-Sized Plasmid DNA Transfection
    Masatoshi Maeki, Shuya Uno, Kaisei Sugiura, Yusuke Sato, Yoichiro Fujioka, Akihiko Ishida, Yusuke Ohba, Hideyoshi Harashima, Manabu Tokeshi · 2023 · ACS Applied Materials & Interfaces
  32. Disrupting bile acid metabolism by suppressing Fxr causes hepatocellular carcinoma induced by YAP activation
    Yuchen Liu, Juanjuan Zhu, Yu Jin, Zhonghe Sun, Xiaolin Wu, Huiping Zhou, Yingzi Yang · 2025 · Nature Communications
  33. Application of CRISPR/Cas to Understand Cis- and Trans-Regulatory Elements in Plants
    Felix Wolter, Holger Puchta · 2018 · Methods in molecular biology
  34. NFIA differentially controls adipogenic and myogenic gene program through distinct pathways to ensure brown and beige adipocyte differentiation
    Yuta Hiraike, Hironori Waki, Kana Miyake, Takahito Wada, Misato Oguchi, Kaede Saito, Shuichi Tsutsumi, Hiroyuki Aburatani, Toshimasa Yamauchi, Takashi Kadowaki · 2020 · PLoS Genetics
  35. Targeting netrin‐3 in small cell lung cancer and neuroblastoma
    Shan Jiang, Mathieu Richaud, Pauline Vieugué, Nicolas Rama, Jean‐Guy Delcros, Maha Siouda, Mitsuaki Sanada, Anna Rita Redavid, Benjamin Ducarouge, Maëva Hervieu et al. · 2021 · EMBO Molecular Medicine
  36. Lupus enhancer risk variant causes dysregulation of IRF8 through cooperative lncRNA and DNA methylation machinery
    Tian Zhou, Xinyi Zhu, Zhizhong Ye, Yongfei Wang, Chao Yao, Ning Xu, Mi Zhou, Jianyang Ma, Yuting Qin, Yiwei Shen et al. · 2022 · Nature Communications
  37. A modular dCas9-based recruitment platform for combinatorial epigenome editing
    Tessa Swain, Christian Pflueger, Saskia Freytag, Daniel Poppe, Jahnvi Pflueger, Trung Viet Nguyen, Ji Kevin Li, Ryan Lister · 2023 · Nucleic Acids Research
  38. Re-engineered RNA-Guided FokI-Nucleases for Improved Genome Editing in Human Cells
    Steven Havlicek, Yang Shen, Yunus Alpagu, Michaela Bianka Bruntraeger, Nurdiana B.M. Zufir, Zhi Yi Phuah, Zhiyan Fu, Norris Ray Dunn, Lawrence Walter Stanton · 2017 · Molecular Therapy
  39. Functional interrogation of non-coding DNA through CRISPR genome editing
    Matthew C. Canver, Daniel E. Bauer, Stuart H. Orkin · 2017 · Methods
  40. CRISPR Genome Engineering for Human Pluripotent Stem Cell Research
    Somali Chaterji, Eun Hyun Ahn, Deok‐Ho Kim · 2017 · Theranostics
  41. Mouse medulloblastoma driven by CRISPR activation of cellular Myc
    Baohan Thi Vo, Jin Ah Kwon, Chunliang Li, David Finkelstein, Beisi Xu, Brent A. Orr, Charles J. Sherr, Martine F. Roussel · 2018 · Scientific Reports
  42. Creation of versatile cloning platforms for transgene expression and dCas9-based epigenome editing
    Jonathan M. Haldeman, Amanda E. Conway, Michelle E. Arlotto, Dorothy H. Slentz, Deborah M. Muoio, Thomas C Becker, Christopher B. Newgard · 2018 · Nucleic Acids Research
  43. From fiction to science: clinical potentials and regulatory considerations of gene editing
    Maria Schacker, Diane Seimetz · 2019 · Clinical and Translational Medicine
  44. Generation and validation of versatile inducible CRISPRi embryonic stem cell and mouse model
    Rui Li, Xianyou Xia, Xing Wang, Xiaoyu Sun, Zhongye Dai, Dawei Huo, Huimin Zheng, Haiqing Xiong, Aibin He, Xudong Wu · 2020 · PLoS Biology
  45. Delivery Platforms for CRISPR/Cas9 Genome Editing of Glial Cells in the Central Nervous System
    Vasco Meneghini, Marco Peviani, Marco Luciani, Giada Zambonini, Angela Gritti · 2021 · Frontiers in Genome Editing
  46. Chromatin Remodeling of Colorectal Cancer Liver Metastasis is Mediated by an HGF‐PU.1‐DPP4 Axis
    Lihua Wang, Ergang Wang, Jorge Prado Balcazar, Zhenzhen Wu, Kun Xiang, Yi Wang, Qiang Huang, Marcos Negrete, Kai‐Yuan Chen, Wei Li et al. · 2021 · Advanced Science
  47. The Role of p38γ in Cancer: From review to outlook
    Wentao Xu, Rui Liu, Ying Dai, Shaocheng Hong, Huke Dong, Hua Wang · 2021 · International Journal of Biological Sciences
  48. Superenhancer activation of KLHDC8A drives glioma ciliation and hedgehog signaling
    Derrick Lee, Ryan C. Gimple, Xujia Wu, Briana C. Prager, Zhixin Qiu, Qiulian Wu, Vikas Daggubati, Aruljothi Mariappan, Jay Gopalakrishnan, Matthew R. Sarkisian et al. · 2022 · Journal of Clinical Investigation
  49. Presynaptic targeting of botulinum neurotoxin type A requires a tripartite PSG‐Syt1‐SV2 plasma membrane nanocluster for synaptic vesicle entry
    Joensuu, Merja, Syed, Parnayan, Saber, Saber H, Lanoue, Vanessa, Wallis, Tristan P, Rae, James, Blum, Ailisa, Gormal, Rachel S, Small, Christopher, Sanders, Shanley et al. · 2023 · The EMBO Journal
  50. Engineered smart materials for RNA based molecular therapy to treat Glioblastoma
    Ravi Raj Singh, Indranil Mondal, Taskeen Iqbal Janjua, Amirali Popat, Ritu Kulshreshtha · 2023 · Bioactive Materials
  51. Methyltransferase METTL8 is required for 3-methylcytosine modification in human mitochondrial tRNAs
    Jenna M. Lentini, Rachel Bargabos, Chen Chen, Dragony Fu · 2022 · Journal of Biological Chemistry
  52. Intratumoral heterogeneity of MYC drives medulloblastoma metastasis and angiogenesis
    Nan Qin, Eunice Paisana, Maike Langini, Daniel J. Picard, Bastian Malzkorn, Carlos Custódia, Rita Cascão, Frauke-Dorothee Meyer, Lena Blümel, Sarah Göbbels et al. · 2022 · Neuro-Oncology
  53. LXRα Promotes Hepatosteatosis in Part Through Activation of MicroRNA‐378 Transcription and Inhibition of Ppargc1β Expression
    Tianpeng Zhang, Jiangyan Duan, Lei Zhang, Zhuoyu Li, Clifford J. Steer, Guiqin Yan, Guisheng Song · 2018 · Hepatology
  54. A genome editing primer for the hematologist
    Megan D. Hoban, Daniel E. Bauer · 2016 · Blood
  55. Applications of CRISPR/Cas9 in the Mammalian Central Nervous System.
    Katherine E. Savell, Jeremy J. Day · 2017 · PubMed Central
  56. CRISPR Interference–Potential Application in Retinal Disease
    Caroline F. Peddle, Lewis E. Fry, Michelle E. McClements, Robert Edward MacLaren · 2020 · International Journal of Molecular Sciences
  57. Global epigenomic analysis of KSHV-infected primary effusion lymphoma identifies functional MYC superenhancers and enhancer RNAs
    Angela Park, Soohwan Oh, Kyle L. Jung, Un Yung Choi, Hye-Ra Lee, Michael G. Rosenfeld, Jae Ung Jung · 2020 · Proceedings of the National Academy of Sciences
  58. Activation of melatonin receptor 1 by CRISPR‐Cas9 activator ameliorates cognitive deficits in an Alzheimer's disease mouse model
    Hanseul Park, Jongpil Kim · 2022 · Journal of Pineal Research
  59. The role of noncoding RNAs in metabolic reprogramming of cancer cells
    Amir Safi, Mohammadreza Saberiyan, Mohammad‐Javad Sanaei, Samaneh Adelian, Fateme Davarani Asl, Mahsa Zeinaly, Mahdi Shamsi, Reza Ahmadi · 2023 · Cellular & Molecular Biology Letters
  60. Cohesin-mediated 3D contacts tune enhancer-promoter regulation
    Philine Guckelberger, Benjamin R. Doughty, Glen Munson, Suhas S.P. Rao, Yingxuan Tan, Xiangmeng Shawn Cai, Charles P. Fulco, Joseph Nasser, Kristy S. Mualim, Drew T. Bergman et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  61. Reversing the Central Dogma: RNA-guided control of DNA in epigenetics and genome editing
    Howard Y. Chang, Lei S. Qi · 2023 · Molecular Cell
  62. CRISPR/Cas9: a powerful tool in colorectal cancer research
    Yang Hu, Liang Liu, Qi Jiang, Weiping Fang, Yazhu Chen, Yuntian Hong, Xiang Zhai · 2023 · Journal of Experimental & Clinical Cancer Research
  63. Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and Are Targetable by BET Bromodomain Inhibition
    Matthew L. Hemming, Matthew A. Lawlor, Jessica L. Andersen, Timothy Hagan, Otari Chipashvili, Thomas G. Scott, Chandrajit P. Raut, Ewa Sicińska, Scott A. Armstrong, George D. Demetri et al. · 2019 · Cancer Research
  64. Blood disease–causing and –suppressing transcriptional enhancers: general principles and GATA2 mechanisms
    Emery H. Bresnick, Kirby D. Johnson · 2019 · Blood Advances
  65. Plant gene expression control using genome- and epigenome-editing technologies
    Gurbachan S. Miglani, Anroop Kaur, Lovepreet Kaur · 2019 · Journal of Crop Improvement
  66. PsychENCODE and beyond: transcriptomics and epigenomics of brain development and organoids
    Alexandre Jourdon, Soraya Scuderi, Davide Capauto, Alexej S. Abyzov, Flora Maria Vaccarino · 2020 · Neuropsychopharmacology
  67. CRISPR-Cas Technology: Emerging Applications in Clinical Microbiology and Infectious Diseases
    Sahar Serajian, Ehsan Ahmadpour, Sonia M. Rodrigues Oliveira, Maria de Lourdes Pereira, Siamak Heidarzadeh · 2021 · Pharmaceuticals
  68. Integrated single-cell profiling dissects cell-state-specific enhancer landscapes of human tumor-infiltrating CD8+ T cells
    Dania Riegel, Elena Romero-Fernández, Malte Simon, Akinbami Raphael Adenugba, Katrin Singer, Roman Mayr, Florian Weber, Mark Kleemann, Charles David Imbusch, Marina P Kreutz et al. · 2023 · Molecular Cell
  69. Harnessing CRISPR technology for viral therapeutics and vaccines: from preclinical studies to clinical applications
    Farzaneh Zahedipour, Fatemeh Zahedipour, Parvin Zamani, Mahmoud Reza Jaafari, Amirhossein Sahebkar · 2024 · Virus Research
  70. Effects of super-enhancers in cancer metastasis: mechanisms and therapeutic targets
    Shenglan Liu, Wei Dai, Bei Jin, Feng Jiang, Hao Huang, Wen Hou, Jin‐Xia Lan, Yanli Jin, Weijie Peng, Jingxuan Pan · 2024 · Molecular Cancer
  71. LINE1 and PRC2 control nucleolar organization and repression of the 8C state in human ESCs
    Juan Zhang, Lamisa Ataei, Kirti Mittal, Liang Li Wu, Lauren Caldwell, Linh Huynh, Shahil Sarajideen, Kevin Y. Tse, Marie-Michelle Simon, Md. Abdul Mazid et al. · 2024 · Developmental Cell
  72. Engineered CRISPR Systems for Next Generation Gene Therapies
    Michael Pineda, Farzaneh Moghadam, Mo R. Ebrahimkhani, Samira Kiani · 2017 · ACS Synthetic Biology
  73. CD38 Causes Autophagic Flux Inhibition and Cardiac Dysfunction Through a Transcriptional Inhibition Pathway Under Hypoxia/Ischemia Conditions
    Xingyue Zhang, Lingfei Li, Qiong Zhang, Qinglin Wei, Jiezhi Lin, Jiezhi Jia, Junhui Zhang, Tiantian Yan, Yanling Lv, Xupin Jiang et al. · 2020 · Frontiers in Cell and Developmental Biology
  74. CRISPR mediated targeting of DUX4 distal regulatory element represses DUX4 target genes dysregulated in Facioscapulohumeral muscular dystrophy
    Sunny Das, Brian Paul Chadwick · 2021 · Scientific Reports
  75. Contextual Reprogramming of CAR-T Cells for Treatment of HER2+ Cancers
    Zhifen Yang, Lingyu Li, Ahu Turkoz, Pohan Chen, Rona Harari-Steinfeld, Maggie L. Bobbin, Ofir Stefanson, Hana Choi, Violena Pietrobon, Bennett Alphson et al. · 2020 · Journal of Translational Medicine
  76. Pooled genetic screens with image‐based profiling
    Russell T. Walton, Avtar K Singh, Paul C. Blainey · 2022 · Molecular Systems Biology
  77. Induced mutation and epigenetics modification in plants for crop improvement by targeting CRISPR/Cas9 technology
    Muhammad Hafeez Ullah Khan, Shahid Ullah Khan, Muhammad Ali, Limin Hu, Yang Yang, Chuchuan Fan · 2017 · Journal of Cellular Physiology
  78. Genome Engineering with TALE and CRISPR Systems in Neuroscience
    Han B. Lee, Brynn N. Sundberg, Ashley N. Sigafoos, Karl J. Clark · 2016 · Frontiers in Genetics
  79. Role of MYC in B Cell Lymphomagenesis
    Petra Korać, Snježana Dotlić, Maja Matulić, Matea Zajc Petranović, Mara Dominis · 2017 · Genes
  80. Genetically engineered mouse models for studying radiation biology
    Katherine D. Castle, Mark Chen, Amy J. Wisdom, David G. Kirsch · 2017 · Translational Cancer Research
  81. Development of a multi-locus CRISPR gene drive system in budding yeast
    Yao Yan, Gregory C. Finnigan · 2018 · Scientific Reports
  82. Using CRISPR to understand and manipulate gene regulation
    Ersin Akıncı, Marisa C. Hamilton, Benyapa Khowpinitchai, Richard I. Sherwood · 2021 · Development
  83. dCas9 fusion to computer-designed PRC2 inhibitor reveals functional TATA box in distal promoter region
    Shiri Levy, Logeshwaran Somasundaram, Infencia Xavier Raj, Diego Ic-Mex, Ashish Phal, Sven Schmidt, Weng I. Ng, Daniel Mar, Justin A. Decarreau, Nicholas Moss et al. · 2022 · Cell Reports
  84. EWS::FLI1 and HOXD13 Control Tumor Cell Plasticity in Ewing Sarcoma
    April Ann Apfelbaum, Feinan Wu, Allegra G. Hawkins, Brian Magnuson, Jennifer A. Jiménez, Sean D. Taylor, Emma D. Wrenn, Olivia G. Waltner, Elise R. Pfaltzgraff, Jane Y. Song et al. · 2022 · Clinical Cancer Research
  85. Krüppel-like factor 5 rewires NANOG regulatory network to activate human naive pluripotency specific LTR7Ys and promote naive pluripotency
    Zhipeng Ai, Xinyu Xiang, Yangquan Xiang, Iwona Szczerbinska, Yuli Qian, Xiao Xu, Chenyang Ma, Yaqi Su, Bing Gao, Hao Shen et al. · 2022 · Cell Reports
  86. Enhancement of protein translation by CRISPR/dCasRx coupled with SINEB2 repeat of noncoding RNAs
    Congcong Cao, Aolin Li, Chaojie Xu, Baorui Wu, Jun Liu, Yuchen Liu · 2023 · Nucleic Acids Research
  87. Emerging strategies to improve heat stress tolerance in crops
    Jiawei Xiong, Hao Wang, Zhaohui Zhong, Shigui Li, Peng Qin · 2025 · aBIOTECH
  88. Targeting Oncogenic Super Enhancers in MYC-Dependent AML Using a Small Molecule Activator of NR4A Nuclear Receptors
    S. Greg Call, Ryan P. Duren, Anil K. Panigrahi, Loc Nguyen, Pablo R. Freire, Sandra L. Grimm, Cristian Coarfa, Orla M. Conneely · 2020 · Scientific Reports
  89. Identifying Novel Enhancer Elements with CRISPR-Based Screens
    Jason C. Klein, Wei Chen, Molly J. Gasperini, Jay Shendure · 2018 · ACS Chemical Biology
  90. CRISPR Tools for Systematic Studies of RNA Regulation
    J Engreitz, Omar O. Abudayyeh, Jonathan S. Gootenberg, Feng Zhang · 2019 · Cold Spring Harbor Perspectives in Biology
  91. Genome-scale CRISPR-Cas9 screening in stem cells: theories, applications and challenges
    Heng Zhou, Ye Peng, Wei Xiong, Xingxiang Duan, Shuili Jing, Yan He, Zhi Rong Zeng, Yen Wei, Qingsong Ye · 2024 · Stem Cell Research & Therapy
  92. Locally acting transcription factors regulate p53-dependent cis-regulatory element activity
    Allison N. Catizone, Gizem Karsli Uzunbas, Petra Celadova, Sylvia Kuang, Daniel A. Bose, Morgan A. Sammons · 2020 · Nucleic Acids Research
  93. The evolution and history of gene editing technologies
    Shubhchintan Randhawa, Shatakshi Sengar · 2021 · Progress in molecular biology and translational science
  94. Genome-wide CRISPR interference screen identifies long non-coding RNA loci required for differentiation and pluripotency
    Jeffrey R. Haswell, Kaia Mattioli, Chiara Gerhardinger, Philipp G. Maass, Daniel J. Foster, Paola Peinado, Xiaofeng Wang, Pedro P. Medina, John L. Rinn, Frank John Slack · 2021 · PLoS ONE
  95. CDK12 orchestrates super‐enhancer‐associated CCDC137 transcription to direct hepatic metastasis in colorectal cancer
    Dai, Wei, Wu, Junhong, Peng, Xiaopeng, Hou, Wen, Huang, Hao, Cheng, Qilai, Liu, Zhiping, Luyten, Walter, Schoofs, Liliane, Zhou, Jingfeng et al. · 2022 · Clinical and Translational Medicine
  96. Activation of the imprinted Prader-Willi syndrome locus by CRISPR-based epigenome editing
    Dahlia Rohm, Joshua B. Black, Sean R. McCutcheon, Alejandro Barrera, Shanté S. Berry, Daniel J. Morone, Xander Nuttle, Celine E. de Esch, Derek J.C. Tai, Michael E. Talkowski et al. · 2025 · Cell Genomics
  97. Inhibition of replication of hepatitis B virus using transcriptional repressors that target the viral DNA
    Kristie M. Bloom, Haajira Kaldine, Toni Cathomen, Claudio Mussolino, Abdullah Ely, Patrick B. Arbuthnot · 2019 · BMC Infectious Diseases
  98. Epigenome editing by CRISPR/Cas9 in clinical settings: possibilities and challenges
    Wendi Pei, Yan Zhang, Tailang Yin, Yang Yu · 2019 · Briefings in Functional Genomics
  99. The Complex Network between MYC Oncogene and microRNAs in Gastric Cancer: An Overview
    Ana Carolina Anauate, Mariana Ferreira Leal, Danielle Queiroz Calcagno, Carolina Oliveira Gigek, Bruno Takao Real Karia, Fernanda Wisnieski, Leonardo Caires Santos, Elizabeth Chen, Rommel Mário Rodríguez Burbano, Marı́lia de Arruda Cardoso Smith · 2020 · International Journal of Molecular Sciences
  100. Transcriptional repression of PTEN in neural cells using CRISPR/dCas9 epigenetic editing
    Colette Moses, Stuart I. Hodgetts, Fiona Nugent, Guy Ben-Ary, Kevin Kyungsuk Park, Pilar Blancafort, Alan R. Harvey · 2020 · Scientific Reports